Form Type: 4

SEC EDGAR Link
Accession Number:0001127602-20-016580
Date:2020-05-12
Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
Original Submission Date:

Reporting Person:

LEVIN ALAN G
4505 EMPEROR BLVD.
SUITE 200 DURHAM, NC 27703

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
AUTOMATIC STOCK OPTION GRANT 5.41 2020-05-12 deemed execution date A 40,000 (a) 2021-05-12 2030-05-12 common stock 40,000 $5.41 40,000 direct
Footnotes
IDfootnote
f1 automatic non-employee director grant pursuant to the biocryst pharmaceuticals, inc. stock incentive plan.
WhaleWisdom Logo

Elevate your investments